Evidence map›Paper›PMID 28410379›Full record

ArticlePloS one2017

New insights into valve-related intramural and intracellular bacterial diversity in infective endocarditis.

Andreas Oberbach, Nadine Schlichting, Stefan Feder, Stefanie Lehmann, Yvonne Kullnick, Tilo Buschmann, Conny Blumert, Friedemann Horn, Jochen Neuhaus, Ralph Neujahr and 13 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Biomarkers in the Light of the Etiopathology of IC/BPS.Diagnostics (Basel, Switzerland) · 2021
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Identification ofSpinal cord series and cases · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 7 institutions in 2 countries.

Andreas OberbachDepartment of Diagnostics, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Nadine SchlichtingDepartment of Diagnostics, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Stefan FederUniversity of Leipzig/Heart Center Leipzig, Department of Cardiac Surgery, Leipzig, Germany.
Stefanie LehmannDepartment of Diagnostics, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Yvonne KullnickDepartment of Diagnostics, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Tilo BuschmannDepartment of Diagnostics, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Conny BlumertDepartment of Diagnostics, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Friedemann HornDepartment of Diagnostics, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Jochen NeuhausDepartment of Urology, University of Leipzig, Leipzig, Germany.
Ralph NeujahrCarl Zeiss Microscopy GmbH, Global Sales Support Life Sciences Microscopy Labs Munich, Munich, Germany.
Erik BagaevDepartment of Cardiac Surgery, Ludwig-Maximilians-University, Munich, Germany.
Christian HaglDepartment of Cardiac Surgery, Ludwig-Maximilians-University, Munich, Germany.
Maximilian PichlmaierDepartment of Cardiac Surgery, Ludwig-Maximilians-University, Munich, Germany.
Arne Christian RodloffInstitute for Medical Microbiology and Epidemiology of Infectious Diseases, Leipzig University Hospital, Leipzig, Germany.
Sandra GräberInstitute for Medical Microbiology and Epidemiology of Infectious Diseases, Leipzig University Hospital, Leipzig, Germany.
Katharina KirschUniversity of Leipzig, Heart Centre, Department of Internal Medicine/Cardiology, Leipzig, Germany.
Marcus SandriUniversity of Leipzig, Heart Centre, Department of Internal Medicine/Cardiology, Leipzig, Germany.
Vivek KumbhariDepartment of Medicine and Division of Gastroenterology and Hepatology. The Johns Hopkins Medical Institutions, Baltimore, Maryland, United States of America.
Armirhossein BehzadiUniversity of Leipzig/Heart Center Leipzig, Department of Cardiac Surgery, Leipzig, Germany.
Amirali BehzadiUniversity of Leipzig/Heart Center Leipzig, Department of Cardiac Surgery, Leipzig, Germany.
Joao Carlos CorreiaUniversity of Leipzig/Heart Center Leipzig, Department of Cardiac Surgery, Leipzig, Germany.
Friedrich Wilhelm MohrUniversity of Leipzig/Heart Center Leipzig, Department of Cardiac Surgery, Leipzig, Germany.
Maik FriedrichDepartment of Diagnostics, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.ORCID http://orcid.org/0000-0002-7221-4222
Fraunhofer Institute for Cell Therapy and Immunology · DELeipzig Heart Institute · DELudwig-Maximilians-Universität München · DEJohns Hopkins University · USUniversity Hospital Leipzig · DECarl Zeiss (Germany) · DELeipzig University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsIn infective endocarditis (IE), a severe inflammatory disease of the endocardium with an unchanged incidence and mortality rate over the past decades, only 1% of the cases have been described as polymicrobial infections based on microbiological approaches. The aim of this study was to identify potential biodiversity of bacterial species from infected native and prosthetic valves. Furthermore, we compared the ultrastructural micro-environments to detect the localization and distribution patterns of pathogens in IE. MATERIAL AND

methodsUsing next-generation sequencing (NGS) of 16S rDNA, which allows analysis of the entire bacterial community within a single sample, we investigated the biodiversity of infectious bacterial species from resected native and prosthetic valves in a clinical cohort of 8 IE patients. Furthermore, we investigated the ultrastructural infected valve micro-environment by focused ion beam scanning electron microscopy (FIB-SEM).

resultsBiodiversity was detected in 7 of 8 resected heart valves. This comprised 13 bacterial genera and 16 species. In addition to 11 pathogens already described as being IE related, 5 bacterial species were identified as having a novel association. In contrast, valve and blood culture-based diagnosis revealed only 4 species from 3 bacterial genera and did not show any relevant antibiotic resistance. The antibiotics chosen on this basis for treatment, however, did not cover the bacterial spectra identified by our amplicon sequencing analysis in 4 of 8 cases. In addition to intramural distribution patterns of infective bacteria, intracellular localization with evidence of bacterial immune escape mechanisms was identified.

conclusionThe high frequency of polymicrobial infections, pathogen diversity, and intracellular persistence of common IE-causing bacteria may provide clues to help explain the persistent and devastating mortality rate observed for IE. Improved bacterial diagnosis by 16S rDNA NGS that increases the ability to tailor antibiotic therapy may result in improved outcomes.

Indexed as

AgedAged, 80 and overBacteriaEndocarditisFemaleHeart ValvesHigh-Throughput Nucleotide SequencingHumansMaleMetagenomeMicroscopy, Electron, ScanningMiddle AgedPhenotypeRNA, Ribosomal, 16SSequence Analysis, DNARNA, Ribosomal, 16S

Identifiers

PMID28410379
PMCPMC5391965
OpenAlexW2606015934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.